How much revenue does Comera Life Sciences make?

Comera Life Sciences reported $633,102 in revenue for fiscal year 2022, up 97.9% from $319,832 in fiscal year 2021. In Q3 2023 revenue was $136,310.

What companies are similar to Comera Life Sciences?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Curative Biosciences, Inc. (CBDX), Hemagen Diagnostics, Inc. (HMGN), Sienna Biopharmaceuticals, Inc. (SNNAQ), Indvr Brands Inc. (CAAOF).

Comera Life Sciences Holdings, Inc. (CMRA) Stock

About Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachuset...

At a glance

Comera Life Sciences reported revenue of $633,102 for fiscal year 2022, up 97.9% from fiscal year 2021, and net income of -$18.38 million. In Q3 2023 (the quarter ended September 30, 2023) revenue was $136,310, down 42.0% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2022.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.